Qinghai Spring Medicinal Resources Technology (600381.SH) announces a preliminary estimate of a net loss of 145 million to 174 million yuan for the year 2024.
ST Spring (600381.SH) released its performance forecast for the year 2024, and the company expects its attributable...
Qinghai Spring Medicinal Resources Technology (600381.SH) announces its performance forecast for 2024, with an estimated net loss attributable to shareholders of the listed company of 145 million to 174 million RMB, and a net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses of 117 million to 146 million RMB.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
